Inicio › Cáncer del colon y del recto › Ohio

Ensayos clínicos de Cáncer del colon y del recto en Ohio

62 estudios sobre Cáncer del colon y del recto buscan participantes en Ohio.

Ciudades en Ohio

Texto oficial del estudio (inglés)

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Case Western, University Hospitals Cleveland Medical Center, Cleveland

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07659795

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06102902

The Vanguard Study: Testing a New Way to Screen for Cancer

Louis Stokes Cleveland VA Medical Center, Cleveland

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Good Samaritan Hospital - Cincinnati, Cincinnati
Bethesda North Hospital, Cincinnati
TriHealth Cancer Institute-Westside, Cincinnati
y 1 más

ReclutandoFase 3Se aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07018869

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Akron
Clinical Study Site, Canton
Clinical Study Site, Cincinnati
y 4 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07228832

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Summa Health System - Akron Campus, Akron
Cleveland Clinic Akron General, Akron
Summa Health System - Barberton Campus, Barberton
y 44 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Indu and Raj Soin Medical Center, Beavercreek
Strecker Cancer Center-Belpre, Belpre
Saint Elizabeth Boardman Hospital, Boardman
y 11 más

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06418204

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The Ohio State University (OSU) Wexner Medical Center, Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Cleveland Clinic - Oncology Department, Cleveland

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06760819

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

University Hospitals Cleveland Medical Center, Cleveland
The Jame Outpatient Care West Campus, Columbus

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07397338

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Gabrail Cancer Center, Canton
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic Cancer Center Fairview Hospital Moll Pavilion, Cleveland
y 8 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06662786

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Gabrail Cancer Center, Canton
University Hospital of Cleveland, Cleveland

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06750094

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Gabrail Cancer & Research Center, Canton

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT05856981

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

UH Cleveland Medical Center, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07542704

Family Communications After Genetic Testing

Aultman Alliance Community Hospital, Alliance
Indu and Raj Soin Medical Center, Beavercreek
Saint Elizabeth Boardman Hospital, Boardman
y 17 más

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07143487

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Miami Valley Hospital South, Centerville
Ohio State University Comprehensive Cancer Center, Columbus
Miami Valley Hospital, Dayton
y 5 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT05673148

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Cleveland Clinic, Taussig Cancer Institute, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06720987

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Cleveland Clinic, Cleveland
Ohio State University, Columbus
Taylor Cancer Research Center, Maumee

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT03526835

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

University of Cincinnati Cancer Institute, Cincinnati
Case Comprehensive Cancer Center, Cleveland
Ohio State University-Arthur G James Comprehensive Cancer Center, Columbus
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07284849

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

University Hospitals - UH Cleveland Medical Center, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT07094204

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Cleveland Clinic, Cleveland
Ohio State University, Columbus

ReclutandoFase 1/2

Edades de 18 a 90 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06710756

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT05803382

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT06820463

JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

Cleveland Clinic Foundation, Cleveland

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06973564

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

The Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT04981119

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07221357

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Oncology Hematology Care Primary, Cincinnati
Taylor Cancer Research Center, Maumee

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT04657068

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Oncology Hematology Care - Blue Ash /ID# 280143, Cincinnati

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07525206

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT06654037

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Cleveland Clinic Foundation, Cleveland
Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT05630794

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Ohio State University, Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06026410

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Cleveland Clinic, Cleveland

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT05786924

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Oncology Hematology Care - Eastgate, Cincinnati
University Hospitals Cleveland Medical Center, Cleveland
Oncology Hematology Care Clinical Trials, LLC, Fairfield

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222800

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
Cleveland Clinic, Cleveland

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Cleveland Clinic, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT04429542

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

University of Cincinnati Cancer Center, Cincinnati

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07544589

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

The Cleveland Clinic Taussig Cancer Center, Cleveland

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #10, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05176483

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 10, Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07085091

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Ohio State University Comprehensive Cancer Center, Columbus
Saint Elizabeth Youngstown Hospital, Youngstown

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT05863195

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.